- Home
- TAP vs RGC Comparison
TAP vs RGC Comparison
Compare TAP & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAP
- RGC
- Stock Information
- Founded
- TAP 1873
- RGC 2014
- Country
- TAP United States
- RGC Hong Kong
- Employees
- TAP N/A
- RGC N/A
- Industry
- TAP Beverages (Production/Distribution)
- RGC Medicinal Chemicals and Botanical Products
- Sector
- TAP Consumer Staples
- RGC Health Care
- Exchange
- TAP Nasdaq
- RGC Nasdaq
- Market Cap
- TAP 10.1B
- RGC 8.4B
- IPO Year
- TAP N/A
- RGC 2021
- Fundamental
- Price
- TAP $43.72
- RGC $16.65
- Analyst Decision
- TAP Hold
- RGC
- Analyst Count
- TAP 14
- RGC 0
- Target Price
- TAP $53.43
- RGC N/A
- AVG Volume (30 Days)
- TAP 2.1M
- RGC 194.3K
- Earning Date
- TAP 11-04-2025
- RGC 10-24-2025
- Dividend Yield
- TAP 4.31%
- RGC N/A
- EPS Growth
- TAP N/A
- RGC N/A
- EPS
- TAP 5.06
- RGC N/A
- Revenue
- TAP $11,283,200,000.00
- RGC N/A
- Revenue This Year
- TAP N/A
- RGC N/A
- Revenue Next Year
- TAP $0.55
- RGC N/A
- P/E Ratio
- TAP $8.64
- RGC N/A
- Revenue Growth
- TAP N/A
- RGC N/A
- 52 Week Low
- TAP $42.94
- RGC $0.09
- 52 Week High
- TAP $64.66
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- TAP 31.99
- RGC 48.15
- Support Level
- TAP $45.15
- RGC $15.79
- Resistance Level
- TAP $47.24
- RGC $17.45
- Average True Range (ATR)
- TAP 0.91
- RGC 1.11
- MACD
- TAP -0.23
- RGC -0.01
- Stochastic Oscillator
- TAP 17.03
- RGC 37.65
About TAP Molson Coors Beverage Company Class B
Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the US, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the US, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.